Llwytho...
The PHGDH enigma: do cancer cells only need serine or also a redox modulator?
Upregulation of serine biosynthesis pathway activity is an increasingly apparent feature of many cancers. Most notably, the first rate-limiting enzyme of the pathway, phosphoglycerate dehydrogenase (PHGDH), is genomically amplified in some melanomas and breast cancers and can be transcriptionally re...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cancer Lett |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7092752/ https://ncbi.nlm.nih.gov/pubmed/32032680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2020.01.036 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|